Why are non-steroidal anti-inflammatory drugs important in peptic ulceration?-Reference-Cited by-同舟云学术

Why are non-steroidal anti-inflammatory drugs important in peptic ulceration?

Published:2007-03-31 Issue: Volume:1 Page:540s-547s
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

PORRO G. BIANCHI,PACE F.,CARUSO I.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1987.tb00663.x/fullpdf

Reference15 articles.

1. Effect of aspirin on the human stomach in normals; endoscopic comparison of damage produced 1 hour, 24 hours and 2 weeks after administration;O'Laughlin;Scand J Gastroenterol,1981

2. Gastroduodenal damage due to drugs, alcohol and smoking;Domschke;Clin Gastroenterol,1984

3. Drug-induced gastric mucosal injury;Fromm;World J Surg,1981

4. Cytoprotection by prostaglandins;Robert;Gastroenterology,1979

5. Effects of acetylsalicylate on alkalisation, acid secretion and electrogenic properties in isolated gastric mucosa;Garner;Acta Physiol Scand,1977

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of widely used non-steroidal anti-inflammatory drugs in biological fluids using simultaneous derivatization and air-assisted liquid–liquid microextraction followed by gas chromatography–flame ionization detection;Journal of the Iranian Chemical Society;2015-09-21

2. Review article: controversies in NSAID-induced gastroduodenal damage-do they matter?;Alimentary Pharmacology & Therapeutics;2007-03-31

3. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects;Digestive and Liver Disease;2001-12

4. An Overview of the Key Role of Misoprostol in the Prophylaxis of Nsaid-Associated Ulcers and Their Complications;Side Effects of Anti-Inflammatory Drugs IV;1997

5. An overview of the key role of misoprostol in the prophylaxis of NSAID-associated ulcers and their complications;Inflammopharmacology;1996-03